Skip to main content

Alphabet Inc.'s Form 4 filing

Prime Medicine, Inc. (PRME) · filed Oct 26, 2022

Accession no.
0001628280-22-027126
Filed
Oct 26, 2022, 8:02 PM ET
Trade date
Oct 24, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market purchases total $13.6M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Alphabet Inc.CIK 0001652044Other: Member of a 10% Group
GV 2019 GP, L.L.C.CIK 000184503810% Owner
GV 2019 GP, L.P.CIK 000184503910% Owner
GV 2019, L.P.CIK 000184504110% Owner
GV 2021, L.P.CIK 0001861202Other: Member of a 10% Group
GV 2021 GP, L.L.C.CIK 0001861206Other: Member of a 10% Group
GV 2021 GP, L.P.CIK 0001861216Other: Member of a 10% Group

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 24, 2022Common StockCConversionAcquired+10,722,248––10,722,248Indirect
Oct 24, 2022Common StockCConversionAcquired+1,762,440––1,762,440Indirect
Oct 24, 2022Common StockPPurchaseAcquired+800,000$17.00+$13,600,00011,522,248Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Oct 24, 2022Common StockCConversionDisposed−10,722,248$0.00$00Indirect
Oct 24, 2022Common StockCConversionDisposed−1,762,440$0.00$00Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)